Eric Crombez's Insider Trades & SAST Disclosures
Eric Crombez's most recent trade in Ultragenyx Pharmaceutical Inc. was a trade of 30,246 Stock Ooption (Right to Buy) done . Disclosure was reported to the exchange on March 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Eric Crombez.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical ... | Eric Crombez | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 30,246 | 30,246 | - | - | Stock Ooption (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Eric Crombez | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 16,813 | 65,244 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | Eric Crombez | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 14,971 | 80,215 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | Eric Crombez | EVP and Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 42.10 per share. | 01 Mar 2025 | 8,945 | 71,922 (0%) | 0% | 42.1 | 376,585 | Common Stock |
| Abeona Therapeutics Inc | Eric Crombez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 36,101 | 47,145 (0%) | 0% | 0 | Common Stock | |
| Abeona Therapeutics Inc | Eric Crombez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 11,044 | 11,044 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | Eric Crombez | EVP and Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 43.66 per share. | 02 May 2024 | 354 | 48,431 (0%) | 0% | 43.7 | 15,456 | Common Stock |
| Ultragenyx Pharmaceutical ... | Eric Crombez | EVP and Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 44.10 per share. | 18 Apr 2024 | 142 | 48,785 (0%) | 0% | 44.1 | 6,262 | Common Stock |
| Ultragenyx Pharmaceutical ... | Eric Crombez | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 34,200 | 34,200 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Eric Crombez | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 19,400 | 49,912 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | Eric Crombez | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 2,351 | 2,351 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Eric Crombez | EVP and Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 53.76 per share. | 01 Mar 2024 | 1,238 | 48,927 (0%) | 0% | 53.8 | 66,555 | Common Stock |
| Ultragenyx Pharmaceutical ... | Eric Crombez | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2023 | 8,362 | 8,362 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Eric Crombez | EVP and Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2023 | 4,658 | 30,512 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges